CUAMC
RCKT icon

China Universal Asset Management Company’s Rocket Pharmaceuticals RCKT Stock Holding History

China Universal Asset Management Company’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.4K Sell
17,378
-1,888
-10% -$6.28K ﹤0.01% 451
2026
Q1 		$69K Buy
19,266
+1,631
+9% +$6.48K 0.01% 441
2025
Q4 		$61.9K Sell
17,635
-1,279
-7% -$4.38K ﹤0.01% 440
2025
Q3 		$61.7K Sell
18,914
-2,725
-13% -$8.58K 0.01% 417
2025
Q2 		$53K Buy
21,639
+251
+1% +$1.27K 0.01% 414
2025
Q1 		$143K Buy
21,388
+2,059
+11% +$20.3K 0.01% 338
2024
Q4 		$243K Buy
19,329
+1,824
+10% +$27.5K 0.02% 314
2024
Q3 		$323K Buy
17,505
+6,839
+64% +$140K 0.04% 263
2024
Q2 		$230K Sell
10,666
-6,699
-39% -$154K 0.03% 222
2024
Q1 		$468K Buy
17,365
+6,941
+67% +$197K 0.06% 188
2023
Q4 		$312K Buy
10,424
+8,356
+404% +$184K 0.06% 173
2023
Q3 		$42.4K Buy
2,068
+1,014
+96% +$18.4K 0.01% 239
2023
Q2 		$20.9K Sell
1,054
-21
-2% -$424 0.01% 264
2023
Q1 		$18.4K Buy
1,075
+306
+40% +$5.99K 0.01% 228
2022
Q4 		$15K Buy
769
+151
+24% +$2.78K 0.01% 197
2022
Q3 		$10K Buy
+618
New +$9.64K ﹤0.01% 208

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

China Universal Asset Management Company's RCKT Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Rocket Pharmaceuticals (RCKT) stake by 9.8% in Q2 2026, selling an estimated $6.28K and leaving 17,378 shares worth $59.4K. The position accounts for ﹤0.01% of the portfolio, ranked #451.

China Universal Asset Management Company first reported a position in RCKT in Q3 2022 and has held it in 16 quarters since. The position peaked at $468K in Q1 2024. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • China Universal Asset Management Company held 17,378 shares of Rocket Pharmaceuticals worth $59.4K as of Q2 2026.
  • China Universal Asset Management Company sold 1,888 Rocket Pharmaceuticals shares in Q2 2026, an estimated $6.28K.
  • Rocket Pharmaceuticals made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #451 holding.
  • China Universal Asset Management Company first reported a position in Rocket Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Rocket Pharmaceuticals position peaked at $468K in Q1 2024.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.